Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings
Authors' conclusion
We reached consensus on multiple domains and items that should be assessed in an open label, 12-month clinical juvenile SSc trial as well as a research agenda for future development.
Study context
- Population
- 27-member multidisciplinary team (paediatric and adult rheumatologists, dermatologists, paediatric cardiologists, pulmonologists, gastroenterologists, a statistician, patients) proposing outcomes for juvenile systemic sclerosis (SSc) trialsmultidisciplinary team
- Participants
- 27 participants
- Outcome
- Agreed domains and outcome measures for an open-label 12-month juvenile SSc trial
Methodological details4 face-to-face consensus meetings, nominal group technique, multidisciplinary team
- 4 face-to-face consensus meetings
- Nominal group technique
- Multidisciplinary team
Recommendations
As reported in the abstract
Outcome measures with 100% agreement
14
Item with 91% agreement
1
Item with 86% agreement
1
Original publication
Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings. Arthritis Care Res (Hoboken). Published 12 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →